Cytomegalovirus and transplant arteriopathy: Evidence for a link is mounting, but the jury is still out

Transplantation

Volumn 75, Issue 6, 2003, Pages 742-743

  Vamvakopoulos, Joannis ^b   Häyry, Pekka ^a  

^a BIOMEDICUM HELSINKI   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; ENDOTHELIN 1; GROWTH FACTOR;

ARTERY INTIMA PROLIFERATION; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM CELL; GRAFT FAILURE; HEART TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; INTRAVASCULAR ULTRASOUND; MAJOR HISTOCOMPATIBILITY COMPLEX; NOTE; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VIRUS INFECTIVITY;

CORONARY ARTERIOSCLEROSIS; CYTOMEGALOVIRUS INFECTIONS; HEART TRANSPLANTATION; HUMANS; POSTOPERATIVE COMPLICATIONS;

EID: 0345118184     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000054929.87347.59     Document Type: Note

References (14)

1. Rifkind D, Goodman N, Hill RB Jr. The clinical significance of cytomegalovirus infection in renal transplant recipients. Ann Intern Med 1967; 66(6): 1116.
2. Bieber CP, Stinson EB, Shumway NE, et al. Cardiac transplantation in man. VII. Cardiac allograft pathology. Circulation 1970; 41(5): 753.
3. Grattan MT, Moreno-Cabral CE, Starnes VA, et al. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. J Am Med Assoc 1989; 261: 3561.
4. Koskinen PK, Kallio EA, Tikkanen JM, et al. Cytomegalovirus infection and cardiac allograft vasculopathy. Transpl Infect Dis 1999; 1(2): 115.
5. Gulizia JM, Kandolf R, Kendall TJ, et al. Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts. Am J Pathol 1995; 147(2): 461.
6. Sambiase NV, Higuchi ML, Nuovo G, et al. CMV and transplant-related coronary atherosclerosis: an immunohistochemical, in situ hybridisation, and polymerase chain reaction in situ study. Mod Pathol 2000; 13(2): 173.
7. Kofoed KF, Czernin J, Johnson J, et al. Effects of cardiac allograft vasculopathy on myocardial blood flow, vasodilatory capacity and coronary vasomotion. Circulation 1997; 95(3): 600.
8. Lim TT, Liang DH, Botas J, et al. Role of compensatory enlargement and shrinkage in transplant coronary artery disease: serial intravascular ultrasound study. Circulation 1997; 95(4): 855.
9. Pethig K, Heublein B, Wahlers T, et al. Mechanism of luminal narrowing in cardiac allograft vasculopathy: inadequate vascular remodeling rather than intimal hyperplasia is the major predictor of coronary artery stenosis. Am Heart J 1998; 135(4): 628.
10. Tsutsui H, Ziada KM, Schoenhagen P, et al. Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5-year serial intravascular ultrasound study. Circulation 2001; 104(6): 653.
11. Simonson MS, Herman WH, Robinson A, et al. Inhibition of endothelin-converting enzyme attenuates transplant vasculopathy and rejection in rat cardiac allografts. Transplantation 1999; 67(12): 1542.
12. Shirali GS, Ni J, Chinnock RE, et al. Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med 2001; 344(20): 1498.
13. Nagano H, Nadeau KC, Kusaka M, et al. Infection-associated macrophage activation accelerates chronic renal allograft rejection in rats. Transplantation 1997; 64(11): 1602.
14. Danenberg HD, Welt FG, Walker M III, et al. Systemic inflammation induced by lipopolysaccharide increases neointimal formation after balloon and stent injury in rabbits. Circulation 2002; 105(24): 2917.